| Ulcerative Colitis |
1 |
1 |
| Thromboembolism |
0 |
0.63 |
| Colitis |
0 |
0.53 |
| Food and Drug Administration (FDA) |
0 |
0.53 |
| Inflammatory Bowel Disease |
0 |
0.46 |
| Biologic Therapy |
0 |
0.42 |
| Skin Cancer |
0 |
0.36 |
| Cancer |
0 |
0.27 |
| Ovarian Vein Thrombosis |
0 |
0.26 |
| Nonmelanoma Skin Cancer |
0 |
0.25 |
| Cerebrovascular Accident |
0 |
0.24 |
| Pulmonary Embolism |
0 |
0.21 |
| Thrombus |
0 |
0.19 |
| Anemia |
0 |
0.18 |
| Blood |
0 |
0.18 |
| Clinical Research |
0 |
0.18 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.18 |
| Opportunistic Infection |
0 |
0.18 |
| Thrombosis |
0 |
0.18 |
| Vein |
0 |
0.18 |
| Deep Venous Thrombosis |
0 |
0.16 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.15 |
| Herpes Zoster |
0 |
0.15 |
| HIV Infection |
0 |
0.15 |
| Neutropenia |
0 |
0.15 |
| Vasculitis |
0 |
0.15 |
| Acne |
0 |
0.13 |
| Dermatitis |
0 |
0.13 |
| Skin and Soft Tissue Infection |
0 |
0.13 |
| Pneumonia |
0 |
0.12 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.12 |
| Psoriatic Arthritis |
0 |
0.11 |
| Abscess |
0 |
0.09 |
| Anus |
0 |
0.09 |
| Arthritis |
0 |
0.09 |
| Atopic Dermatitis |
0 |
0.09 |
| Embolism |
0 |
0.09 |
| Giant Cell Arteritis |
0 |
0.09 |
| Heart |
0 |
0.09 |
| Minnesota |
0 |
0.09 |
| Nebraska |
0 |
0.09 |
| Outpatient Clinic |
0 |
0.09 |
| Peer Review |
0 |
0.09 |
| Rectal Hemorrhage |
0 |
0.09 |
| Remission |
0 |
0.09 |
| Takayasu Arteritis |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Tyrosine Kinase |
0 |
0.09 |
| Crohn Disease |
0 |
0.08 |
| Headache |
0 |
0.08 |
| Health Care Reform |
0 |
0.08 |
| Tuberculosis |
0 |
0.08 |